vs

Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and Marathon Bancorp, Inc. (MBBC). Click either name above to swap in a different company.

Marathon Bancorp, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.1M, roughly 2.0× Insight Molecular Diagnostics Inc.). Marathon Bancorp, Inc. runs the higher net margin — 22.3% vs -2015.4%, a 2037.7% gap on every dollar of revenue. On growth, Marathon Bancorp, Inc. posted the faster year-over-year revenue change (41.7% vs -23.4%). Marathon Bancorp, Inc. produced more free cash flow last quarter ($1.4M vs $-7.0M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs 20.3%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Marathon Bancorp, Inc. is a Maryland-based financial holding company that primarily operates through its community bank subsidiary. It offers a full range of retail and commercial banking products including deposit accounts, consumer loans, commercial mortgages, and small business financing, serving individual and small-to-medium enterprise customers across local markets in Maryland.

IMDX vs MBBC — Head-to-Head

Bigger by revenue
MBBC
MBBC
2.0× larger
MBBC
$2.2M
$1.1M
IMDX
Growing faster (revenue YoY)
MBBC
MBBC
+65.0% gap
MBBC
41.7%
-23.4%
IMDX
Higher net margin
MBBC
MBBC
2037.7% more per $
MBBC
22.3%
-2015.4%
IMDX
More free cash flow
MBBC
MBBC
$8.4M more FCF
MBBC
$1.4M
$-7.0M
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
20.3%
MBBC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
IMDX
IMDX
MBBC
MBBC
Revenue
$1.1M
$2.2M
Net Profit
$-23.0M
$501.4K
Gross Margin
42.5%
Operating Margin
-2057.5%
26.2%
Net Margin
-2015.4%
22.3%
Revenue YoY
-23.4%
41.7%
Net Profit YoY
31.5%
880.7%
EPS (diluted)
$-0.75
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMDX
IMDX
MBBC
MBBC
Q4 25
$1.1M
$2.2M
Q3 25
$260.0K
$2.1M
Q2 25
$518.0K
$1.9M
Q1 25
$2.1M
$1.7M
Q4 24
$1.5M
$1.6M
Q3 24
$115.0K
$1.6M
Q2 24
$104.0K
$1.6M
Q1 24
$176.0K
$1.6M
Net Profit
IMDX
IMDX
MBBC
MBBC
Q4 25
$-23.0M
$501.4K
Q3 25
$-10.9M
$444.3K
Q2 25
$-9.7M
$-332.0K
Q1 25
$-6.7M
$148.4K
Q4 24
$-33.5M
$51.1K
Q3 24
$-13.5M
$174.9K
Q2 24
$-4.5M
$85.8K
Q1 24
$-9.1M
$-631.1K
Gross Margin
IMDX
IMDX
MBBC
MBBC
Q4 25
42.5%
Q3 25
53.5%
Q2 25
67.6%
Q1 25
62.0%
Q4 24
40.0%
Q3 24
43.5%
Q2 24
48.1%
Q1 24
25.6%
Operating Margin
IMDX
IMDX
MBBC
MBBC
Q4 25
-2057.5%
26.2%
Q3 25
-4249.2%
25.5%
Q2 25
-1900.0%
-25.7%
Q1 25
-318.0%
11.6%
Q4 24
-2262.9%
3.3%
Q3 24
-11752.2%
13.4%
Q2 24
-4453.8%
4.1%
Q1 24
-5265.3%
-53.7%
Net Margin
IMDX
IMDX
MBBC
MBBC
Q4 25
-2015.4%
22.3%
Q3 25
-4174.6%
20.7%
Q2 25
-1880.7%
-18.9%
Q1 25
-312.0%
8.9%
Q4 24
-2255.1%
3.2%
Q3 24
-11733.0%
10.8%
Q2 24
-4355.8%
6.2%
Q1 24
-5186.9%
-40.7%
EPS (diluted)
IMDX
IMDX
MBBC
MBBC
Q4 25
$-0.75
$0.19
Q3 25
$-0.34
$0.17
Q2 25
$-0.30
$-0.13
Q1 25
$-0.26
$0.07
Q4 24
$-2.19
$0.02
Q3 24
$-0.98
$0.06
Q2 24
$-0.36
$0.07
Q1 24
$-1.13
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMDX
IMDX
MBBC
MBBC
Cash + ST InvestmentsLiquidity on hand
$11.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-31.5M
$46.9M
Total Assets
$25.8M
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMDX
IMDX
MBBC
MBBC
Q4 25
$11.6M
Q3 25
$18.7M
Q2 25
$24.3M
Q1 25
$31.0M
Q4 24
$8.6M
Q3 24
$3.4M
Q2 24
$9.3M
Q1 24
$5.6M
Stockholders' Equity
IMDX
IMDX
MBBC
MBBC
Q4 25
$-31.5M
$46.9M
Q3 25
$-9.2M
$46.3M
Q2 25
$1.1M
$45.7M
Q1 25
$10.2M
$32.0M
Q4 24
$-12.3M
$31.7M
Q3 24
$9.7M
$31.6M
Q2 24
$22.7M
$31.3M
Q1 24
$11.6M
$31.4M
Total Assets
IMDX
IMDX
MBBC
MBBC
Q4 25
$25.8M
$248.0M
Q3 25
$43.9M
$246.0M
Q2 25
$50.5M
$238.8M
Q1 25
$60.4M
$236.8M
Q4 24
$35.1M
$217.9M
Q3 24
$70.2M
$216.5M
Q2 24
$74.7M
$219.3M
Q1 24
$71.0M
$225.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMDX
IMDX
MBBC
MBBC
Operating Cash FlowLast quarter
$-5.5M
$1.4M
Free Cash FlowOCF − Capex
$-7.0M
$1.4M
FCF MarginFCF / Revenue
-616.7%
62.3%
Capex IntensityCapex / Revenue
129.9%
0.6%
Cash ConversionOCF / Net Profit
2.82×
TTM Free Cash FlowTrailing 4 quarters
$-25.4M
$3.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMDX
IMDX
MBBC
MBBC
Q4 25
$-5.5M
$1.4M
Q3 25
$-4.5M
$464.0K
Q2 25
$-6.3M
$1.4M
Q1 25
$-5.9M
$849.0K
Q4 24
$-5.4M
$113.6K
Q3 24
$-5.5M
$945.2K
Q2 24
$-6.0M
$416.6K
Q1 24
$-3.8M
$-802.1K
Free Cash Flow
IMDX
IMDX
MBBC
MBBC
Q4 25
$-7.0M
$1.4M
Q3 25
$-5.6M
$456.6K
Q2 25
$-6.6M
$1.3M
Q1 25
$-6.2M
$773.2K
Q4 24
$-5.6M
$105.0K
Q3 24
$-5.6M
$921.6K
Q2 24
$-6.2M
$-1.8M
Q1 24
$-3.9M
$-1.1M
FCF Margin
IMDX
IMDX
MBBC
MBBC
Q4 25
-616.7%
62.3%
Q3 25
-2135.4%
21.3%
Q2 25
-1279.5%
66.0%
Q1 25
-288.4%
46.3%
Q4 24
-374.5%
6.6%
Q3 24
-4884.3%
57.1%
Q2 24
-5931.7%
-118.5%
Q1 24
-2189.8%
-67.9%
Capex Intensity
IMDX
IMDX
MBBC
MBBC
Q4 25
129.9%
0.6%
Q3 25
403.8%
0.3%
Q2 25
67.4%
9.3%
Q1 25
14.4%
4.5%
Q4 24
14.4%
0.5%
Q3 24
75.7%
1.5%
Q2 24
183.7%
145.2%
Q1 24
13.6%
16.2%
Cash Conversion
IMDX
IMDX
MBBC
MBBC
Q4 25
2.82×
Q3 25
1.04×
Q2 25
Q1 25
5.72×
Q4 24
2.22×
Q3 24
5.40×
Q2 24
4.85×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons